Search filters

List of works by Kotaro Shide

Acute myeloid leukemia in clinical practice: a retrospective population-based cohort study in Miyazaki Prefecture, Japan ⬇️

scientific article published on July 24, 2012

Calreticulin mutant mice develop essential thrombocythemia that is ameliorated by the JAK inhibitor ruxolitinib

scientific article published on 3 November 2016

Clinical features and treatment outcomes of isolated secondary central nervous system lymphomas in Miyazaki Prefecture ⬇️

scientific article published on September 10, 2011

Differences in Hematological and Clinical Features Between Essential Thrombocythemia Cases With JAK2- or CALR-Mutations.

scientific article published on March 2017

Early/prefibrotic primary myelofibrosis in patients who were initially diagnosed with essential thrombocythemia

scientific article published on 09 July 2018

Effect of NS-018, a selective JAK2V617F inhibitor, in a murine model of myelofibrosis

scientific article published on 10 January 2014

Effects of mogamulizumab in adult T-cell leukemia/lymphoma in clinical practice.

scientific article published on 2 February 2017

Efficacy and safety of sofosbuvir and ledipasvir in Japanese patients aged 75 years or over with hepatitis C genotype 1.

scientific article published in December 2017

Efficacy of NS-018, a potent and selective JAK2/Src inhibitor, in primary cells and mouse models of myeloproliferative neoplasms ⬇️

scientific article published on July 22, 2011

Essential thrombocytosis attributed to JAK2-T875N germline mutation

scientific article published on 19 August 2019

Hmga2 collaborates with JAK2V617F in the development of myeloproliferative neoplasms

scientific article published on 14 June 2017

Integrated molecular analysis of adult T cell leukemia/lymphoma.

scientific article published on 5 October 2015

JAK2-negative acute monocytic leukemia with TET2 mutation in essential thrombocythemia with JAK2 mutation with literature review

scientific article published on 16 January 2020

Loss of Tyrosine Kinase 2 Does Not Affect the Severity of Jak2V617F-induced Murine Myeloproliferative Neoplasm.

scientific article published in July 2017

Mice with Calr mutations homologous to human CALR mutations only exhibit mild thrombocytosis

scientific article published on 29 March 2019

Monocyte-derived fibrocytes elimination had little contribution on liver fibrosis

scientific article published on 21 February 2019

Mutant calreticulin causes essential thrombocythemia

scientific article

Outcome of allogeneic hematopoietic cell transplantation in patients with adult T-cell leukemia

scientific article published on 10 September 2018

Potentiated activation of VLA-4 and VLA-5 accelerates proplatelet-like formation ⬇️

scientific article published on May 29, 2012

Prognostic relevance of integrated genetic profiling in adult T-cell leukemia/lymphoma.

scientific article

Real-World Data on Clinical Features, Outcomes, and Prognostic Factors in Multiple Myeloma from Miyazaki Prefecture, Japan

scientific article published on 30 December 2020

Splenic irradiation provides transient palliation for symptomatic splenomegaly associated with primary myelofibrosis: a report on 14 patients

scientific article published on 20 January 2016

TET2 Mutation in Adult T-Cell Leukemia/Lymphoma

scientific article published on January 2015

TET2 is essential for survival and hematopoietic stem cell homeostasis ⬇️

scientific article published on April 3, 2012

TP53 and PTEN mutations were shared in concurrent germ cell tumor and acute megakaryoblastic leukemia

scientific article published on 02 January 2020

The role of driver mutations in myeloproliferative neoplasms: insights from mouse models

scientific article published on 21 December 2019

Tyrosine kinase 2 interacts with the proapoptotic protein Siva-1 and augments its apoptotic functions ⬇️

scientific article published on August 19, 2010

Vitamin D receptor-mediated skewed differentiation of macrophages initiates myelofibrosis and subsequent osteosclerosis

scientific article published on 04 February 2019

[Molecularly pathogenesis and molecular targeted therapy for myeloproliferative neoplasms].

scientific article

Paulina is supported by:

About Paulina

Help